| scholarly article | Q13442814 |
| P2093 | author name string | K Yamaguchi | |
| S Miyazaki | |||
| Y Ishii | |||
| T Matsumoto | |||
| Y Hirakata | |||
| K Tateda | |||
| N Furuya | |||
| A Ohno | |||
| P2860 | cites work | Translocation of Escherichia coli from the gastrointestinal tract to the mesenteric lymph nodes in gnotobiotic mice receiving Escherichia coli vaccines before colonization | Q33911673 |
| Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat. | Q34543905 | ||
| Generation and characterization of murine antiflagellum monoclonal antibodies that are protective against lethal challenge with Pseudomonas aeruginosa. | Q35108367 | ||
| Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia | Q35808176 | ||
| Opsonophagocytosis of Pseudomonas aeruginosa treated with antiflagellar serum. | Q37009930 | ||
| Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia | Q37012345 | ||
| Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide | Q37026057 | ||
| Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice | Q39783620 | ||
| Effects of a human antiflagellar monoclonal antibody in combination with antibiotics on Pseudomonas aeruginosa infection | Q39874977 | ||
| A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide | Q40149450 | ||
| Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa | Q40149884 | ||
| Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide | Q40181441 | ||
| Differentiation of the major flagellar antigens of Pseudomonas aeruginosa by the slide coagglutination technique. | Q40218729 | ||
| In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice. | Q40267457 | ||
| Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide. | Q40600347 | ||
| Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies | Q41380349 | ||
| Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients | Q43496476 | ||
| Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients | Q44870761 | ||
| Mortality rates amongst mice with endogenous septicaemia caused by Pseudomonas aeruginosa isolates from various clinical sources | Q45248076 | ||
| Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats | Q46205804 | ||
| Patterns of cytokine expression in community-acquired pneumonia | Q46847960 | ||
| Pulmonary infection complicating intra-abdominal sepsis: clinical and experimental observations | Q47650900 | ||
| Synthesis of complement by guinea pig bronchoalveolar macrophages. Effect of acute and chronic infection with Pseudomonas aeruginosa | Q53916663 | ||
| Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis. | Q64911806 | ||
| Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation | Q67946473 | ||
| Cytokine serum level during severe sepsis in human IL-6 as a marker of severity | Q68088881 | ||
| Variable cross-reactivity of Pseudomonas aeruginosa lipopolysaccharide-code-specific monoclonal antibodies and its possible relationship with serotype | Q68096404 | ||
| Role of elastase as a virulence factor in experimental Pseudomonas aeruginosa infection in mice | Q68175289 | ||
| Thermal injury promotes bacterial translocation from the gastrointestinal tract in mice with impaired T-cell-mediated immunity | Q68792919 | ||
| Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations | Q68953062 | ||
| Flagellar antibody stimulated opsonophagocytosis of Pseudomonas aeruginosa associated with response to either a- or b-type flagellar antigen | Q69242287 | ||
| Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum | Q70369678 | ||
| Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa | Q70409112 | ||
| Flagella, motility and invasive virulence of Pseudomonas aeruginosa | Q70409124 | ||
| Adverse effects of tumour necrosis factor in cyclophosphamide-treated mice subjected to gut-derived Pseudomonas aeruginosa sepsis | Q73820423 | ||
| Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice | Q74502669 | ||
| Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice | Q74502674 | ||
| Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gut-derived sepsis with Pseudomonas aeruginosa | Q77753121 | ||
| Role of Motility in the Endogenous Pseudomonas aeruginosa Sepsis after burn | Q88432938 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| sepsis | Q183134 | ||
| P304 | page(s) | 537-541 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice | |
| P478 | volume | 6 |
| Q42036438 | Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections |
| Q42119085 | Indole and 7-hydroxyindole diminish Pseudomonas aeruginosa virulence |
| Q33876419 | Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11. |
| Q37937369 | Recent developments for Pseudomonas vaccines |
Search more.